R
Aileron Therapeutics (RNTX)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Aileron Therapeutics (RNTX)
Aileron Therapeutics, Inc. is a clinical-stage chemoprotection oncology company. It is focused on developing medicines to make chemotherapy safer. Its ALRN-6924 product is a MDM2/MDMX dual inhibitor that leverages its peptide drug technology, which i... Read more
- USD1.91
- USD1.91
- USD1.59
- USD5.00
- 3.50%
- --
- 33.57k
- 42M
- 1.35
- -64.80%
Stock News
3 hours ago
Porsche cuts outlook on China woes, U.S. tariffs
MarketWatch
6 hours ago
Opera: Fantastic Results Prove Bull Case Is Just Getting Started
SeekingAlpha
6 hours ago
F5, Inc. Q2 Earnings: A Strong Free Cash Flow Machine At A Reasonable Price
SeekingAlpha
7 hours ago
Resilience Is The New Alpha: Rethinking Risk In A Fragile World
SeekingAlpha
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
